Success Stories: NIW Approved for Biomedical Science Researcher Advancing Regenerative Seed Cells, Cancer Gene Targets, and Medical Education Innovation

 

Client’s Testimonial:

“Thank you very much for your excellent work.”


On February 25th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: February 25th, 2025

Processing Time: 1 year, 3 months, 16 days


Case Summary:     

North America Immigration Law Group (NAILG) presented a proposed endeavor that integrates regenerative medicine, oncology, and medical-education innovation. The petition explains how developing seed cells for tissue and organ repair, identifying actionable gene targets for cancer, and modernizing basic medical training together advance U.S. diagnostics, therapy design, and workforce readiness.

Research Focus and Contributions
 ● Vision restoration research using gene therapy, small-molecule modulation of retinal pathways, and stem-cell-derived retinal progenitors for functional repair.

● Oncology studies are establishing a transcription-factor pathway as a biomarker and driver of metastasis, offering targets for therapy development.

● An integrated medical-curriculum framework that strengthens problem- and case-based learning with cross-disciplinary tools.

Research Impact and Metrics
Peer-Reviewed Publications: 42 journal articles and 3 book chapters.

Citations: 166 independent citations, including a paper ranked in a top citation percentile for its year.

Peer-Review Service: At least 5 invited reviews for recognized journals.

Here is an anonymized excerpt from a recommendation letter that underscores the practical impact of her work:

“The [client] advances regenerative ophthalmology by clarifying molecular mechanisms of stem-cell differentiation and reducing barriers like tumorigenesis and immune rejection. In proliferative vitreoretinopathy models, [client] combined CRISPR/Cas9 nickase with a survivin-targeting small molecule to curb epithelial-to-mesenchymal transition, proliferation, and migration in retinal pigment epithelial cells. In glaucoma models, embryonic stem-cell–derived precursors migrated to the damaged retina and differentiated into retinal ganglion cells after transplantation. In retinitis pigmentosa models, purmorphamine activation of Müller glia yielded rod-like photoreceptors, highlighting a path to functional repair, work reflected by invitations to review for leading journals.”

Demonstrating Substantial Merit and National Importance
We showed substantial merit by tying this work to urgent needs in eye disease and women’s cancer care, and national importance by linking it to the economic burden of vision loss and to physician-workforce shortages that improved training can address. Independent citations, percentile performance for a flagship article, expert letters, and a forward plan demonstrate significance beyond any single institution.

Well Positioned to Advance the Proposed Endeavor
The client’s advanced training, ongoing U.S. research role, publication and citation record, and invitations to judge the work of others establish a clear capacity to continue delivering clinically relevant discoveries and education tools that benefit U.S. healthcare systems.

NIW Approval and Outlook
Approved in 1 year, 3 months, and 16 days, this NIW recognizes a research agenda that strengthens U.S. diagnostics, cancer-therapy targeting, and medical-education efficiency. NAILG is proud to have guided this case and looks forward to the client’s continued contributions to regenerative medicine, oncology, and next-generation clinical training.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.


approval_table_2017

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.